2/ Some background:
* Historically, infants and children are given antibiotics until blood cultures are negative at 48-72 hours.
*Empirically treating is essential for children with bacteremia, but waiting for this negative BC period may be unnecessary. pubmed.ncbi.nlm.nih.gov/25567785/
3/ Why we did this study:
* Understanding the time it takes for blood cultures to become positive (with respect to certain organisms and subspecialties) can help shorten overall antimicrobial duration.
*Shortening duration= fewer adverse events, less resistance, shorter stays
4 / What we did:
* Retrospective analysis of 6,184 blood cultures with positive results over a 6-year period at a large quaternary-care pediatric hospital.
* Included:
-All pts who had BC drawn from Jan 2013- Dec 2018
-Only 1st pos results included
5/ What we did (continued)
*A cx was considered a 1st pos if it had a new organism or if 2 weeks had elapsed since previous positive cx.
*Demographic and #microbiology data were collected
*Cx collect date and date/time that growth was first reported to providers collected
6/ The #microbiology
*#Lab uses standardized BC methods
*Routine BCs incubated for 5 days
*When pos --> Gram stain, BCID (PCR), sub-cultured to BAP/MAC/CHOC/BRUC & incubated (and specialty media added as necessary i.e., chromogenic media or CNA)
7/ The #microbiology continued...
* Media plates incubated for 18-24 hours and examined for growth.
*Orgs identified by MALDI-TOF MS and/or basic biochemical methods
8/ How we categorized things:
*Organisms were categorized into Gram-positive definite pathogens, Gram-negative definite pathogens, Gram-positive possible pathogens, yeast, common contaminants, and "other uncommon definite pathogens" (<30 BCs + for that org during study period)
9/ How we categorized things, continued:
* Possible pathogens were defined as those treated by the primary team with directed antimicrobial agents >= 3 days
* Contaminants defined as those that were either not treated, or treated <3 days
10 / The stats:
*Time to positivity (TTP) was calculated based on the date/time a cx was collected and when the GS was first reported by microbiology to the clinician.
*# of pts who would need to be treated for 48 hrs vs 36 to prevent 1 case of abx termination before pos result
11/ Results
*After exclusions, 2,148 positive BC results were analyzed
* 69% grew definite or possible pathogens
*31% grew common contaminants
*68% of cultures were pos at 24 hours
*87% of cultures were pos at 36 hours
*93% of cultures were post at 48 hours
12 /
* When looking at ALL blood cultures obtained during the 6-year period (89,663), only 125 cultures (0.14%) were positive between 36 and 48 hours.
* The median TTP for all included BCs positive for bacteria during this study period was 19.83 (14.4-26.0)
13 / Broken down by organism category, median TTP:
* Gram-pos definite = 15.93 (13.06-19.41)
*Gram-neg definite = 14.33 (11.60-18.35)
*Gram-pos possible = 20.74 (14.36-25.80)
*contams = 24.48 (21.19-32.27)
*yeast = 32.50 (20.08-44.54)
*uncommon paths = 24.90 (17.67-39.07)
14/ Sub-specialty analysis was also performed based on the patient's treatment team:
Of the 2,121 pts with 1st pos blood cultures:
*21% = Hem/Onc/BMT
*15% = PICU
*10%=GI
*14% = NICU
*9% = CICU
Remainder = hospital medicine service
15 /
*When comparing the TTPs for all treated pathogens among the NICU, PICU and CICU, there wasn't a difference between groups
*Longer median TTPs were observed in the NICU with MSSA, MRSA, and Streptococcus species.
16 / Putting it all together: 1. This study suggests that 36 hours is sufficient for observation of blood cultures in infants and children who are receiving empiric antimicrobial treatment out of concern for bacteremia (87% of BCs positive by 36 hours).
17/
2. This study suggests that early de-escalation is appropriate in a clinically stable patient. This will likely require safety-netting with robust education, strict return precautions, etc.
18/
3. The longest median TTP in this study was for yeast, at 32.50 hours.
4. There was no significant difference in TTP w/ respect to source (CVC vs peripheral draw) or treatment team.
**These findings are consistent with previously published literature
19 / Why is this unique?
Size, pathogen type 🦠, treatment team💊!
To quote from the manuscript:
With this study, we wanted
to address the common statement heard on #stewardship rounds of “that study was not
done in patients similar to mine.”
20/ If you just want the overarching conclusion of the study, it's this:
"The probability of true bacteremia after 36 hrs is low enough that the # of children needed to be treated beyond that time window to prevent 1 case of
premature termination is likely excessive" #Stewardship
21/ The impact:
If practice was changed to 36 hours hospital-wide, thousands of days of unnecessary antimicrobial therapy could be avoided, also reducing associated downstream effects of such therapy. #IDTwitter
22/ This was led by PharmD extraordinaire @ChristineMacBr1 and senior authored by the one and only @HandshakeASP -- both of which run a powerful #stewardship team at @ChildrensColo. Work would not have been possible without Manon Williams, Kelly Pearce and Dustin Lamb as well.
And for those who would like it all wrapped up nice and pretty...
2/ First, just a quick note on writing for @ASMicrobiology. Volunteering my time to write has been one of the highlights of the last 2 yrs for me! So grateful for the amazing Bugs & Drugs team, especially @JulieMarieWolf@JClinMicro@ScienceInTheDMV who took a chance on me.
3/
YELLOW FEVER AND FRACTIONAL DOSES #Publichealth piece discussing the yellow fever outbreak of 2015/16 in Africa & highlighting the amazing work of researchers working on fractional #vaccine dosing. It's an amazing story, full of impressive characters. asm.org/Articles/2021/…
2 / This is a follow up article to the one I wrote back in May that briefly detailed the history of #YellowFever in the United States, and how the development of #diagnostics for the disease as well as modern research stemmed from that #history. asm.org/Articles/2021/…
3/ The #YellowFever#outbreak that started in Angola in 2015 ravaged major cities like Luanda & Kinshasa, and resulted in 11 imported cases in China - a country that harbors the mosquito that spreads the yellow fever virus and has a population immunologically naïve to YF.
2/ First, I want to emphasize that this project highlights many of the reasons I chose to pursue a #PhD in clinical & translational science. As a long-time microbiologist, I can say that the clinical lab doesn't often have a seat at the clinical effectiveness / research table.
3/ This project focuses on the tracheal aspirate culture- a diagnostic process that is greatly limited by contamination with normal respiratory flora, and which lacks consensus or standardization across labs and hospitals. @ASCLS@ASMicrobiology@ASCP_Chicago
1/Dr. Lewis Roberts is giving a really interesting talk at @ACTScience#TS21 that walks us through the art of reviewing and questioning a scientific talk.
We are all pretty familiar with reviewing manuscripts, but I think this is a fresh take! @EdgeforScholars#phdlife#PhD
2/ This is like a dynamic (real-time) manuscript review. The corollary:
* One key for presenters: strategically repeat yourself
*Tell them what you're going to say (abstract)
*Tell them (introduction, methods, results)
*Tell them what you told them (discussion) #TS21@ACTScience
3/ The 40,000 ft view:
*What is the main aim of the study? Should be in the first few minutes of a presentation
*When you are listening, pick out:
-What is the problem they are trying to solve?
-What is the overall hypothesis? #TS21
3/ Making your own "Scientist Oath" using social media:
If you were making your own platform, what rules would YOU write?
-Be deliberate in thinking about what you share and how you share it
1/Listening to an amazing plenary talk by @DrCHWilkins on racism, disparities, and the role of race/ethnicity in medicine and research. AMAZING talk! #TS21@EdgeforScholars@ACTScience
2/Our focus always seems to be on race alone, and not on other social scenarios. We focus so much on personal choices and access to care-- but we focus less on disparities the way we should (and race as a fully sociopolitical concept). #TS21@ACTScience
3/*Racism in medicine is =responsible for minorities having the worst healthcare & outcomes in the US
*Many famous physicians & scientists were involved in creating and perpetuating inferiority stereotypes
*Many continue to conflate race with biology & physiology #TS21